Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
前日終値
$17.35
+$0.45 · +2.66%
日中の時刻はETです。市場データは遅延する場合があります。
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
日中レンジ
現在 $17.35
52週レンジ
現在 $17.35
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
46
適正価値
センチメント
70
強気
リスク
43
やや高いリスク
モメンタム
69
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
日中レンジ
現在 $17.35
52週レンジ
現在 $17.35
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 1.76億 USD | 2.33億 USD | 2.37億 USD | 2.23億 USD | 2.23億 USD |
| 売上原価 | 9312.3万 USD | 1.34億 USD | 1.33億 USD | 1.26億 USD | 1.26億 USD |
| 粗利益 | 8305.4万 USD | 9933.2万 USD | 1.04億 USD | 9657.7万 USD | 9657.7万 USD |
| 研究開発 | 1704.1万 USD | 1804万 USD | 1572.2万 USD | 1684.3万 USD | 1684.3万 USD |
| 販売・一般管理 | 1.03億 USD | 1.47億 USD | 1.2億 USD | 9756.3万 USD | 9756.3万 USD |
| 営業費用 | 1.2億 USD | 2.14億 USD | 1.36億 USD | 1.14億 USD | 1.14億 USD |
| 支払利息 | 236.1万 USD | 550.3万 USD | 614.2万 USD | 468.9万 USD | 468.9万 USD |
| 減価償却費と償却費 | 2771.2万 USD | 3075.7万 USD | 2748.7万 USD | 2276.5万 USD | 2024.7万 USD |
| 営業利益 | −3680.6万 USD | −1.15億 USD | −3190.4万 USD | −1782.9万 USD | −1782.9万 USD |
| 純利益 | 7830.1万 USD | −9958.7万 USD | −3733.3万 USD | −2.76億 USD | −2.76億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$19.21
上昇余地(10.72%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2015年5月19日 | 1:12 | — | — |
株式分割 | 2010年2月5日 | 1:10 | — | — |
株式分割 | 2005年3月16日 | 8:5 | — | — |
発効済み 2015年5月19日
1:12
発効済み 2010年2月5日
1:10
発効済み 2005年3月16日
8:5
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI2438.19万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM2201.9万0.03%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF936.08万0.01%954億 USD0.05%$235+0.80%
Dimensional - US Small Cap ETFDFAS518.15万0.02%338.69億 USD0.31%$78.35+0.32%
Schwab U.S. Small-Cap ETFSCHA459.12万0.02%218.24億 USD0.03%$32.79+0.40%
Vanguard Russell 2000 ETFVTWO455.27万0.02%180億 USD0.06%$112.66+0.50%
Dimensional - US Core Equity 2 ETFDFAC422.5万0.00%885.96億 USD0.21%$45.33+0.49%
U.S. Micro Cap Portfolio ETFDFMC265.83万0.04%75.58億 USD0.43%$57.813+0.20%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
Schwab U.S. Small-Cap ETFSCHA
Vanguard Russell 2000 ETFVTWO
Dimensional - US Core Equity 2 ETFDFAC
U.S. Micro Cap Portfolio ETFDFMCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。